TUESDAY, Nov. 27, 2018 — Vitrakvi (larotrectinib) has been approved by the U.S. Food and Drug Administration to treat adult and pediatric patients whose cancers have a specific
TUESDAY, Nov. 20, 2018 — Dementia is associated with mortality in most older adults with Down syndrome, according to a study published online Nov. 19 in JAMA Neurology.
There's no cure for psoriasis, a chronic autoimmune condition, and it's often a case of trial and error to find the treatment method that works for you. This
Singing may provide benefits beyond improving respiratory and swallow control in people with Parkinson’s disease, according to new data from Iowa State University researchers. The results from the
FRIDAY, Oct. 26, 2018 — Though the term “functional foods” currently has no legal definition, it’s more than just a clever marketing catchphrase. According to health organizations like
In the spring of 2016, while Emily Lindemer was working toward her Ph.D. at MIT, she was also struggling with something closer to home: watching someone she knew
WEDNESDAY, Oct. 24, 2018 — HIV-infected Hispanics have an increased risk for human papillomavirus (HPV)-related cancers than Hispanics in the general population, according to a study published online
Investigators at Kagoshima University in Japan studied the effect of linalool, a sweet-smelling alcohol that is present in essential oils of lavender and other scented plants, in mice.
CALGARY, Alberta and SAN DIEGO, Oct. 22, 2018 (GLOBE NEWSWIRE) — Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus turning cold